Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 233

1.

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy.

Metz I, Radue EW, Oterino A, Kümpfel T, Wiendl H, Schippling S, Kuhle J, Sahraian MA, Gray F, Jakl V, Häusler D, Brück W.

Acta Neuropathol. 2012 Feb;123(2):235-45. doi: 10.1007/s00401-011-0900-5. Epub 2011 Nov 6.

PMID:
22057786
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.

Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F.

Mult Scler. 2013 Dec;19(14):1826-40. doi: 10.1177/1352458513510224. Epub 2013 Nov 5. Review.

PMID:
24192217
[PubMed - indexed for MEDLINE]
3.

Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.

Kleinschmidt-DeMasters BK, Miravalle A, Schowinsky J, Corboy J, Vollmer T.

J Neuropathol Exp Neurol. 2012 Jul;71(7):604-17. doi: 10.1097/NEN.0b013e31825caf2c. Review.

PMID:
22710964
[PubMed - indexed for MEDLINE]
4.

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

Tan IL, McArthur JC, Clifford DB, Major EO, Nath A.

Neurology. 2011 Sep 13;77(11):1061-7. doi: 10.1212/WNL.0b013e31822e55e7. Epub 2011 Aug 10.

PMID:
21832229
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.

Wüthrich C, Popescu BF, Gheuens S, Marvi M, Ziman R, Denq SP, Tham M, Norton E, Parisi JE, Dang X, Lucchinetti CF, Koralnik IJ.

J Neuropathol Exp Neurol. 2013 Nov;72(11):1043-51. doi: 10.1097/NEN.0000000000000005.

PMID:
24128680
[PubMed - indexed for MEDLINE]
6.

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.

Gheuens S, Smith DR, Wang X, Alsop DC, Lenkinski RE, Koralnik IJ.

Neurology. 2012 May 1;78(18):1390-3. doi: 10.1212/WNL.0b013e318253d61e. Epub 2012 Apr 18.

PMID:
22517104
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.

Dahlhaus S, Hoepner R, Chan A, Kleiter I, Adams O, Lukas C, Hellwig K, Gold R.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1068-74. doi: 10.1136/jnnp-2013-304897. Epub 2013 Apr 19.

PMID:
23606731
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.

Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M.

Ann Neurol. 2012 Nov;72(5):779-87. doi: 10.1002/ana.23676.

PMID:
23280794
[PubMed - indexed for MEDLINE]
9.

Immunological and clinical consequences of treating a patient with natalizumab.

Schwab N, Höhn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Brück W, Wiendl H.

Mult Scler. 2012 Mar;18(3):335-44. doi: 10.1177/1352458511421919. Epub 2011 Sep 9.

PMID:
21908480
[PubMed - indexed for MEDLINE]
10.

Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab.

Blinkenberg M, Sellebjerg F, Leffers AM, Madsen CG, Sørensen PS.

Mult Scler. 2013 Aug;19(9):1226-9. doi: 10.1177/1352458513481010. Epub 2013 Mar 18.

PMID:
23508652
[PubMed - indexed for MEDLINE]
11.

Progressive multifocal leukoencephalopathy after natalizumab discontinuation.

Fine AJ, Sorbello A, Kortepeter C, Scarazzini L.

Ann Neurol. 2014 Jan;75(1):108-15. doi: 10.1002/ana.24051.

PMID:
24242357
[PubMed - indexed for MEDLINE]
12.

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.

Marousi S, Travasarou M, Karageorgiou CE, Gheuens S, Koralnik IJ.

Neurology. 2012 Nov 20;79(21):2160; author reply 2160. doi: 10.1212/01.wnl.0000423208.11698.16. No abstract available.

PMID:
23170016
[PubMed - indexed for MEDLINE]
13.

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.

Clifford DB, De Luca A, Simpson DM, Arendt G, Giovannoni G, Nath A.

Lancet Neurol. 2010 Apr;9(4):438-46. doi: 10.1016/S1474-4422(10)70028-4. Review. Erratum in: Lancet Neurol. 2010 May;9(5):463. DeLuca, Andrea [corrected to De Luca, Andrea].

PMID:
20298967
[PubMed - indexed for MEDLINE]
14.

Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.

Perkins MR, Ryschkewitsch C, Liebner JC, Monaco MC, Himelfarb D, Ireland S, Roque A, Edward HL, Jensen PN, Remington G, Abraham T, Abraham J, Greenberg B, Kaufman C, LaGanke C, Monson NL, Xu X, Frohman E, Major EO, Douek DC.

PLoS Pathog. 2012;8(11):e1003014. doi: 10.1371/journal.ppat.1003014. Epub 2012 Nov 8.

PMID:
23144619
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.

Warnke C, Mausberg AK, Stettner M, Dehmel T, Nekrich L, Meyer zu Horste G, Hartung HP, Fogdell-Hahn A, Adams O, Kieseier BC.

Neurology. 2013 Oct 15;81(16):1400-8. doi: 10.1212/WNL.0b013e3182a84101. Epub 2013 Sep 18.

PMID:
24049136
[PubMed - indexed for MEDLINE]
16.

Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.

Sottini A, Capra R, Zanotti C, Chiarini M, Serana F, Ricotta D, Caimi L, Imberti L.

PLoS One. 2012;7(4):e34493. doi: 10.1371/journal.pone.0034493. Epub 2012 Apr 4.

PMID:
22496817
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation?

Wattjes MP, Verhoeff L, Zentjens W, Killestein J, van Munster ET, Barkhof F, van Eijk JJ.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1176-7. doi: 10.1136/jnnp-2013-304986. Epub 2013 May 21. No abstract available.

PMID:
23695498
[PubMed - indexed for MEDLINE]
18.

Gadolinium enhancement in brain magnetic resonance imaging in progressive multifocal leukoencephalopathy after natalizumab monotherapy: is it really atypical?

Arnaud FX, Hissene A, Métivier D, Dutasta F, Berets O, N'guema B, A'teriitéhau C, Baccialone J, Potet J.

J Neuroradiol. 2012 Oct;39(4):267-70. doi: 10.1016/j.neurad.2011.12.005. Epub 2012 Feb 16.

PMID:
22341620
[PubMed - indexed for MEDLINE]
Free Article
19.

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.

Tan K, Roda R, Ostrow L, McArthur J, Nath A.

Neurology. 2009 Apr 28;72(17):1458-64. doi: 10.1212/01.wnl.0000343510.08643.74. Epub 2009 Jan 7.

PMID:
19129505
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

Lindå H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C.

N Engl J Med. 2009 Sep 10;361(11):1081-7. doi: 10.1056/NEJMoa0810316.

PMID:
19741229
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk